AI scans thousands of journals, studies, and clinical updates every day — so you get what matters, fast. In plain English, or clinical depth. Your choice.
🔬 Enter your email to get started
From $9.99/month. Cancel anytime.
How It Works
DailyDose monitors the world's top medical sources around the clock and distills what's new into a clean, readable daily digest.
Every day, our system crawls PubMed, top journals, clinical trial registries, FDA alerts, and medical newswires.
Duplicate findings are removed. Stories are ranked by clinical significance, recency, and relevance to your interests.
General subscribers get plain English summaries. Clinical subscribers get the full detail — dosing, methodology, implications.
Your morning digest arrives before 7 AM. Browse by specialty, search past issues, or read on the web app.
Who It's For
Whether you're a curious patient or a busy clinician, DailyDose speaks your language.
Stay informed about health and medicine without wading through dense research papers.
Keep up with your specialty without spending hours on literature review.
Sample Digest
Every morning. Concise. Sourced. Actionable.
A Phase III RCTS of finerenone plus standard-of-care reduced heart failure hospitalizations by 34% vs. placebo in patients with HFpEF. Researchers note particularly strong outcomes in patients with T2D comorbidity.
The FDA approved adagrasib plus cetuximab for KRAS G12C-mutated non-small cell lung cancer following promising response rates in the KRYSTAL-10 trial, marking the first doublet approved for this mutation.
A longitudinal study of 490 patients found that specific gut microbiome compositions correlated with faster motor symptom progression in Parkinson's disease, opening potential probiotic intervention pathways.
Pricing
Cancel anytime. Annual plans save 15%.
For anyone who wants to stay on top of health and medical news in plain English.
For healthcare professionals who need clinical depth, specialty filters, and peer-reviewed sourcing.
FAQ
Join DailyDose and get AI-curated medical breakthroughs in your inbox every morning.